| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC) have been net buyers, picking up 300,000 shares worth roughly $3.0M on balance. In the past 30 days, 1 insider bought and 0 sold.
Albert Cha (Chief Executive Officer) stands out among recent buyers, now holding an estimated $3.1M in FLSC.
Counted by filing, the last 12 months brought 1 open-market purchase by 1 insider worth about $3.0M and no sales. There were none in the 12 months before that either.
The largest open-market purchase in the last two years was 300,000 shares by Albert Cha (Chief Executive Officer) at an average $10.00 on October 15, 2026, about $3.0M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 300.0K | $3.05M | +300.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Albert Cha | Chief Executive Officer | Buy | 300,000 | $10.00 | $3,000,000.00 | New |